Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Essential hypertension~Exclusion Criteria:~* Severe hypertension.~* Secondary hypertension.~* Grade III/IV hypertensive retinopathy.~* Type 1 diabetes.~* Cerebrovascular or cardiovascular event during the last 12 months prior to inclusion.~* Pregnant or lactating females.~* History of malignancy within the past five years.~* Shift workers.~* Obstructive sleep apnea.~* Use of disallowed concomitant medication.~* Intolerant to ABPM.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Ramipril on awakening
- 2 (Type: ACTIVE_COMPARATOR): Ramipril at bedtime

Based on this trial design, predict the completion outcome and termination type (if applicable).